Get started
Author

Steffen Dietz

A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications
2017 · Anna‐Lena Volckmar, Holger Sültmann, et al. · Genes Chromosomes and Cancer · 211
Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients
2016 · Anja Lisa Riediger, Steffen Dietz, et al. · Scientific Reports · 59
PDF
Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
2016 · Steffen Dietz, Uwe Schirmer, et al. · PLoS ONE · 52
PDF
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA
2020 · Steffen Dietz, Petros Christopoulos, et al. · EBioMedicine · 48
PDF
Defining molecular risk in ALK+ NSCLC
2019 · Petros Christopoulos, Jan Budczies, et al. · Oncotarget · 43
PDF
Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis
2021 · Arlou Kristina Angeles, Petros Christopoulos, et al. · npj Precision Oncology · 41
PDF
Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival
2019 · Petros Christopoulos, Steffen Dietz, et al. · Cancers · 39
PDF
Analysis of the Binding Moiety Mediating the Interaction between Monocarboxylate Transporters and Carbonic Anhydrase II
2015 · Sina Ibne Noor, Steffen Dietz, et al. · Journal of Biological Chemistry · 34
PDF
Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas
2018 · Steffen Dietz, Aviezer Lifshitz, et al. · International Journal of Cancer · 31
PDF
Circulating MicroRNAs as Potential Biomarkers for Lung Cancer
2019 · Sabrina Müller, Florian Janke, et al. · Recent results in cancer research/Recent Results in Cancer Research · 28
Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas
2017 · Steffen Dietz, Alexander Harms, et al. · International Journal of Cancer · 27
PDF
Earlier extracranial progression and shorter survival in ALK- rearranged lung cancer with positive liquid rebiopsies
2021 · Petros Christopoulos, Steffen Dietz, et al. · Translational Lung Cancer Research · 24
PDF
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in KLC1–ALK-rearranged lung cancer
2019 · Steffen Dietz, Petros Christopoulos, et al. · Molecular Case Studies · 23
PDF
Digital PCR After MALDI–Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma
2018 · Daniel Kazdal, Rémi Longuespée, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 21
Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy
2017 · Steffen Dietz, Holger Sültmann, et al. · Oncotarget · 14
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages
2020 · Florian Janke, Farastuk Bozorgmehr, et al. · Cancers · 4
PDF
Multiple layers of intratumor heterogeneity: clues to clonal evolution of non-small cell lung cancer
2019 · Steffen Dietz, Daniel Kazdal, et al. · Oncotarget · 1
PDF
Abstract 1571: Inter- and intra- tumorheterogeneity of the microenvironment in pulmonary adenocarcinoma
2020 · Daniel Kazdal, Jan Budczies, et al. · Cancer Research
Abstract A21: Longitudinal analysis of cell-free DNA for therapy monitoring of ALK-positive non-small cell lung cancer
2020 · Steffen Dietz, Petros Christopoulos, et al. · Clinical Cancer Research
EP1.11-20 A Panel of Liquid Biomarkers for Early Response Capturing of NSCLC Therapies in Advanced Stages
2019 · F. Janke, M. Schneider, et al. · Journal of Thoracic Oncology
PDF
TP53 status conversion defines an unfavourable patient subset with inferior overall survival in ALK+ lung adenocarcinoma
2019 · P Christopoulos, S Dietz, et al. · Pneumologie
P3.02-032 Spatial Heterogeneity of EGFR and KRAS Variant Allele Frequencies Correlates with Histological Patterns of Lung Adenocarcinomas
2017 · S. Dietz, A. Harms, et al. · Journal of Thoracic Oncology
Chancen und Grenzen der liquid biopsy für die Tumordiagnostik
2015 · Steffen Dietz, Anja Riediger, et al. · BIOspektrum
Works count: 24
Citation count: 700
H-index: 14
I10-index: 15
Year
Topic
Type